That is the catalyst if it gets approved. However a company like TEVA with all their resources is having a problem bringing it to market. Also Sanofi had to pull their device off the market. ADMP already got turned down and is hoping they can get approval. Whoever reviews this for the fda must be pretty tough. So it is no slam dunk that admp is gooing to get approval. As a matter of fact I would say odds are no approval. If they do the stock will sky rocket. If not stock will definitely be under $5 short term if not lower. Recent price action has been very good although all the volume traded today and no move concerns me. IMHO Good Luck to all.
Lol, I saw that too. What a #$%$ article. I am concerned that they had like a 14% drop in the week before earning. Seems like some earning news leaked out to some large institutions. Generally not a good sign before earning release. I can't believe they didn't sell out to TEVA and here they sit at 50% below that price.
Do they actually have a committment to complete the buyout. Based on the way the stock is moving it doesn't look like they are buying back. If I were the agent buying I would wait as it seems like the airlines are tanking. LUV has had a lot of good news and upgrades since earning but has fallen back.
In 2018 they have $100 million of epipen sales. At a 13% profit they make a dollar a share. They submit the nda for their inhaler that has the potential for billions in sales. They get way over valued & pop up to $1 billion in market cap. Their business model is sound if they can execute. Lol, probably won't happen but not out of the question.